Zhitong Finance App News, Zhongyuan Xiehe (600645.SH) issued an announcement. On September 15, 2026, the company received the “Decision on Issuing Warning Letter Measures against Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd., Gong Hongjia, WANG HONGQI (Wang Hongqi), and Chen Yiqing” issued by the Tianjin Regulatory Bureau of the China Securities Regulatory Commission. After investigation, the company announced in July 2025 that it signed a real estate leasing contract with the related party Shanghai Yanli Biotechnology Co., Ltd. (hereinafter referred to as Shanghai Yanli) to rent real estate in Shanghai to establish an East China headquarters and coordinate resource allocation. The company's strategic plan for the establishment of the East China headquarters was not sufficiently verified, the basis was insufficient, and the rationality and necessity of the lease was insufficient. The information disclosed above on transactions relating to the leasing of Shanghai Yanli Real Estate was untrue and inaccurate, in violation of the provisions of Article 3 (1) of the “Administrative Measures on Information Disclosure of Listed Companies” (Securities Regulatory Commission Order No. 226).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.